Choline kinase inhibitors synergize with TRAIL in the treatment of colorectal tumors and overcomes TRAIL resistance

Aim: The aim of this study was to investigate the effects of the combination of choline kinase inhibitor MN58b and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) against colon cancer cells. Methods: TRAIL-sensitive (DLD-1) and TRAIL-resistant (SW620) cells were treated with MN58b an...

Full description

Bibliographic Details
Main Authors: Juan Carlos Lacal, Ladislav Andera
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Cancer Translational Medicine
Subjects:
DR5
Online Access:http://www.cancertm.com/article.asp?issn=2395-3977;year=2016;volume=2;issue=6;spage=163;epage=174;aulast=Lacal

Similar Items